What is Apyx?
Apyx Medical operates as a specialized manufacturer within the medical technology sector, focusing primarily on advanced energy solutions tailored for cosmetic surgery and broader clinical applications. The company distinguishes itself through the production of high-precision devices designed to meet the rigorous requirements of modern surgical environments. By prioritizing research and development, Apyx Medical delivers creative, solution-oriented products that empower physicians to achieve superior patient outcomes. Its market position is defined by a synthesis of engineering excellence and a deep understanding of the evolving needs within the aesthetic and reconstructive surgery markets.
How much funding has Apyx raised?
Apyx has raised a total of $25M across 1 funding round:
Debt
$25M
Debt (2023): $25M with participation from MidCap Financial Investment Corporation
Key Investors in Apyx
MidCap Financial Investment Corporation
MidCap Financial Investment Corporation is a specialized investment firm based in New York that focuses on providing debt financing and capital solutions to middle-market companies.
What's next for Apyx?
Looking ahead, the strategic deployment of the $25M will likely center on expanding the company's operational footprint and refining its product pipeline. As Apyx Medical navigates the complexities of the medical device industry, the focus will remain on scaling production capabilities and potentially exploring new clinical indications for its energy-based technologies. This enterprise-level financing serves as a catalyst for long-term growth, enabling the firm to fortify its competitive advantage and sustain its trajectory as a key innovator in the medical technology space. Future milestones will likely involve increased investment in clinical validation and market penetration strategies to solidify its leadership in the cosmetic surgery domain.
See full Apyx company page
